Shares of Amer Sports were down as much a 7.1 percent in pre-market trading after the company issued first quarter guidance that opened the door to concerns over higher costs. Amer guided first quarter results ending March 31 to adjusted diluted earnings per share in the range of 28 cents to 30 cents on revenue growth at up 22 percent to 24 percent. For the full year ending Dec. 31, 2026, Amer Sports forecasted adjusted diluted EPS at between $1.10 to $1.15, on revenue growth of 16 percent to 18 percent. ...

Infusion Care: Organic growth was 12.5%. Ryder said demand in diabetes remained strong as automated insulin delivery penetration increased, while non-diabetes growth was led by infusion sets for AbbVie’s Parkinson’s disease therapy. Other therapies rose to 15% of infusion care revenue, up from about 10% in 2024.Continence Care: Organic growth was 6.6%, driven by higher U.S. volumes and a growing mix of ConvaTec-branded products. Hydrophilic products were again more than 60% of the category’s revenue, and in ...

Core Viewpoint - Par Pacific Holdings, Inc. is expected to report significant earnings growth for Q4 2025, with an EPS of $1.21, reflecting a 253% year-over-year increase, driven by improved refining margins due to lower crude prices [1] Group 1: Earnings Expectations - The anticipated earnings per share (EPS) for Q4 2025 is $1.21, representing a 253% increase compared to the previous year [1] - Analysts project revenue for the quarter to be $1.71 billion, indicating a decline from previous quarters [3] - Par Pacific's Q3 2025 earnings were $5.95 per share, significantly exceeding the Zacks Consensus Estimate of $1.98, with an average surprise of 77.5% over the last four quarters [2] Group 2: Market Performance - The company's shares opened at $42.15 on February 23, 2026, reflecting market sentiment towards its performance [3] - Par Pacific has a market capitalization of $2.16 billion and a price-to-earnings ratio of 9.03 [4] - The stock has experienced a 52-week low of $11.86 and a high of $48.40, indicating volatility in its market performance [4] Group 3: Technical Indicators - The 50-day moving average for Par Pacific's stock is $38.15, while the 200-day moving average is $37.27, suggesting a positive trend in the short term [4] - The company holds a Zacks Rank 3 and has a 1.25% Earnings ESP, indicating potential for an earnings beat [2]

Core Insights - DNOW Inc. is currently facing significant financial challenges, as evidenced by its earnings per share (EPS) of -$1.04, which is far below the estimated EPS of $0.15 [2][6] - The company's actual revenue of $959 million fell short of the estimated $969.5 million, indicating difficulties in meeting sales targets [3][6] - Despite these challenges, DNOW's price-to-sales ratio of 0.48 suggests that its stock may be undervalued, potentially attracting investors [3] - The negative price-to-earnings (P/E) ratio of approximately -22.53 indicates ongoing losses, but the debt-to-equity ratio of about 0.24 reflects a relatively low level of debt compared to equity [4] - DNOW's strong current ratio of about 2.34 indicates a solid position to meet short-term obligations, despite the negative P/E ratio [5][6] Financial Metrics - EPS of -$1.04, significantly below the estimated $0.15, indicating financial challenges [2][6] - Actual revenue of $959 million, which fell short of the estimated $969.5 million, suggesting difficulties in meeting sales targets [3][6] - Strong current ratio of about 2.34, indicating a good position to meet short-term obligations despite a negative P/E ratio [5][6]

Occidental Petroleum Corporation (NYSE:OXY) has seen a 9% increase in share price following an impressive earnings report.The company has significantly reduced its corporate debt to $15 billion, enhancing its financial stability and future growth potential.Despite a shortfall in revenue, Occidental has increased its oil production and raised its dividend yield by 8%.Occidental Petroleum Corporation, trading under the symbol OXY on the NYSE, is a major player in the oil and gas industry. The company is known ...

Corporate America is sending mixed signals to investors. On earnings calls, executives are talking about softer demand, cautious customers, and the risk of a cooling economy. At the same time, many of those same companies are authorizing billions of dollars in share repurchases.This contradiction has become one of the more interesting financial trends of the moment. Buybacks are climbing even as economic confidence weakens. For investors, the question is whether this reflects genuine belief that stocks are ...

Core Insights - Otter Tail Corporation reported a diluted earnings per share (EPS) of $6.55 for 2025, a decline of 9% from 2024, primarily due to a decrease in the plastics segment performance [4][5][8] - The company announced a 10% increase in its dividend to $2.31 per share, marking the 88th consecutive year of uninterrupted dividend payments [3][8] - Management provided guidance for 2026 with an expected EPS range of $5.22 to $5.62, forecasting a 14% growth in electric earnings but a significant decline of approximately 36% in plastics earnings [6][16][19] Rate Cases and Regulatory Updates - In South Dakota, interim rate revenues of $5.7 million became effective on December 1, 2025, and are subject to refund, with a settlement in principle reached with the South Dakota Public Utilities Commission [1] - The Minnesota Public Utilities Commission approved $28.6 million in interim rate revenues effective January 1, 2026, with final rates expected to be implemented by mid-2027 [2][7] Capital Expenditure and Growth Plans - Otter Tail refreshed its five-year capital expenditure plan totaling $1.9 billion, focusing on renewable energy projects and a battery storage facility with a capacity of 75 MW [7][10][18] - The company is advancing key regulatory and capital initiatives, including a wind repowering project expected to increase output by 20% and extend renewable energy tax credits [9][10] Segment Performance and Future Guidance - For 2026, electric segment earnings are expected to increase by over 7%, driven by rate base recovery and higher volumes, while manufacturing earnings are projected to rise by 7% due to improved sales outlook [16][17] - The plastics segment is anticipated to see a 36% decline in earnings as PVC prices are expected to be about 20% lower than in 2025, with normalization not expected until around 2028 [6][19] Financial Health and Balance Sheet - Otter Tail ended 2025 with $386 million in cash and produced a 16% return on equity, indicating a strong balance sheet capable of funding growth plans without external equity through at least 2030 [15] - The company plans to retire $80 million of parent-level debt maturing in 2026 without replacement, leaving no outstanding parent-level debt [18]

Core Insights - Tenet Healthcare Corporation (THC) reported fourth-quarter 2025 adjusted earnings per share (EPS) of $4.70, exceeding the Zacks Consensus Estimate by 15.2%, with a year-over-year increase of 36.6% [1] - Net operating revenues rose 8.9% year over year to $5.53 billion, surpassing the consensus mark by 1.4% [1] Financial Performance - Adjusted net income for the quarter was $413 million, a 25.2% increase year over year [3] - Adjusted EBITDA improved 12.9% year over year to $1.18 billion, exceeding the estimate of $1.13 billion, with an adjusted EBITDA margin expanding 70 basis points to 21.4% [3] - Salaries, wages, and benefits costs increased 6.1% year over year to $2.2 billion, while supply costs rose 8.6% and net other operating expenses increased 10.8% [4] Segment Performance - Hospital Operations and Services segment recorded net operating revenues of $4.09 billion, up 7.3% year over year, driven by improved Medicaid supplemental revenues and a favorable payer mix [5] - Adjusted EBITDA for the Hospital segment climbed 16.4% year over year to $603 million, with an adjusted EBITDA margin of 14.7%, improving 110 basis points [6] - Ambulatory Care segment's net operating revenues rose 13.8% year over year to $1.43 billion, supported by facility buyouts and expansion of service lines, with adjusted EBITDA at $580 million, a 9.4% increase [7] Financial Position - As of December 31, 2025, Tenet Healthcare had cash and cash equivalents of $2.88 billion, down from $3.02 billion at the end of 2024, while total assets increased to $29.7 billion from $28.9 billion [8] - Long-term debt amounted to $13.1 billion, slightly up from the previous year, with total shareholders' equity increasing to $4.22 billion from $4.17 billion [9] Cash Flow and Share Repurchase - Tenet generated $3.5 billion of net cash from operations in 2025, a 72.9% year-over-year increase, with free cash flows improving 126.7% to $2.5 billion [11] - The company repurchased $198 million in shares during the fourth quarter and $1.4 billion in 2025, with a remaining share repurchase authorization of approximately $1.49 billion [12] 2026 Outlook - Net operating revenues for 2026 are projected to be between $21.5 billion and $22.3 billion, higher than the $21.3 billion in 2025 [13] - Adjusted EBITDA is expected to range from $4.485 billion to $4.785 billion, with an estimated adjusted EBITDA margin of 20.9-21.5%, indicating a potential decline from 2025 [14] - Free cash flow is anticipated to remain between $2.94 billion and $3.29 billion, with capital expenditures projected at $700-$800 million [15]

Core Viewpoint - Alliant Energy Corporation (LNT) has shown mixed performance in the market, with a slight underperformance compared to the broader S&P 500 Index and the Utilities Select Sector SPDR Fund, primarily due to increased operational costs and a decline in adjusted EPS in Q3 2025 [2][3][6]. Financial Performance - LNT's market capitalization is valued at $17.2 billion, providing regulated electricity, natural gas, and water services [1]. - In Q3 2025, LNT reported an adjusted EPS of $1.12, which is a decrease of 2.6% year-over-year, while revenue increased by 11.9% to $1.2 billion [6]. - For the fiscal year ending December 2025, analysts project LNT's EPS to grow by 5.6% to $3.21 on a diluted basis [7]. Stock Performance - Over the past year, LNT's stock has gained 12.5%, underperforming the S&P 500 Index's 15.6% increase, but has outperformed the Utilities Select Sector SPDR Fund, which gained 11.3% [2][3]. - Year-to-date, LNT stock is up 2.9%, compared to the S&P 500's 1.7% rise [2]. Analyst Ratings - Among 12 analysts covering LNT, the consensus rating is a "Moderate Buy," with seven "Strong Buy" ratings and five "Holds" [7]. - Barclays PLC upgraded LNT to an "Equal Weight" rating with a price target of $67, indicating a marginal upside potential [8]. - The mean price target of $72.60 suggests an 8.5% premium to current price levels, while the highest price target of $78 indicates a potential upside of 16.6% [8].

Group 1 - The company reported total sales of MSEK 38,422 for Q4 2025, a decrease from MSEK 41,794 in the same period of the previous year [1] - Organic sales growth for Q4 2025 was 3 percent, down from 4 percent year-over-year, while adjusted organic sales growth remained at 4 percent [1] - Operating income before amortization for Q4 2025 was MSEK 3,063, slightly up from MSEK 3,036, resulting in an operating margin of 8.0 percent compared to 7.3 percent in Q4 2024 [1] Group 2 - For the full year 2025, total sales were MSEK 155,113, down from MSEK 161,921 in 2024, with organic sales growth at 4 percent, a decline from 5 percent [1] - The operating income before amortization for 2025 was MSEK 11,493, an increase from MSEK 11,200, leading to an operating margin of 7.4 percent, up from 6.9 percent [1] - The company proposed a dividend of SEK 5.30 per share for 2025, an increase from SEK 4.50 per share in the previous year [1]